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The hypothesis that ventricular arrhythmias represent
an independent predictor of sudden cardiac death was
examined by analyzing the published data. The fre-
quency and complexity of ventricular arrhythmias in-
crease progressively both with age and severity of heart
disease, but no age- or disease-related norms have been
established for clinical guidance. Simple and complex
arrhythmias, including short runs of ventricular tachy-
cardia, do not increase risk of sudden cardiac death in
subjects without heart disease or with heart disease and
normal myocardial function. Progression of nonsus-
tained into sustained ventricular tachycardia in such in-
dividuals is rare. Simple and complex ventricular ar-
The spectrum of ventricular arrhythmias ranges from a sin-
gle ventricular premature complex to ventricular fibrillation.
The two criteria most widely used in classifying ventricular
arrhythmias in clinical practice are the frequency of ectopic
complexes and the "complexity" of ventricular arrhyth-
mias. The widespread use of ambulatory electrocardio-
graphic (ECG) monitoring during the past two decades has
generated a large amount of data about the frequency and
complexity of ventricular arrhythmias in various population
groups and in patients with various types of heart disease.
The purpose of this report is to review this material, to
evaluate the prognostic significance of ventricular arrhyth-
mias with regard to risk of sudden cardiac death and to
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rhythmias are not strong independentpredictors ofsudden
death in survivors of myocardial infarction. In these,
the overall incidence of sudden cardiac death averages
3.5 to 5% during the first year, but is about 15 to 20%
per year in patients with severely impaired ventricular
function.
The results of this survey suggest that in patients with
well preserved ventricular function, prophylactic use of
antiarrhythmic drugs is not indicated, and that treat-
ment of asymptomatic or mildly symptomatic ventric-
ular arrhythmias is not likely to reduce the incidence of
sudden cardiac death.
() Am Coli CardioI1987;lO:435-47)
discuss the practical implications of the surveyed infor-
mation.
Ventricular Arrhythmias in the Absence of
Heart Disease
Prevalence. Ventricular arrhythmias appear to be more
frequent during the neonatal period than in early childhood.
In one study (I) of 202 newborns, a single ECG examination
revealed eight cases of multiple ventricular premature com-
plexes and three cases of ventricular tachycardia. All of
these newborns apparently "did well." In several other
studies (2), ventricular premature complexes were found in
up to 25% of newborns. That such high prevalence may be
due to the immaturity of the cardiac muscle, conducting
system or autonomic nerves supplying the heart is suggested
by the rarity of ventricular arrhythmias later in infancy and
during early childhood. In children, ventricular arrhythmias
are seldom found during routine ECG examination. In one
study (3) of 500 children and adolescents, aged 4 to 18
years, examined at rest and during treadmill exercise, only
I child had ventricular premature complexes. Similarly,
monitoring revealed only I case of isolated ventricular pre-
mature complexes in 104 healthy children, aged 7 to II
years (4). However, in another study (5) of 131 healthy
boys aged 10 to 13 years, 26% had ventricular premature
0735-1097/87/$3.50
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complexes, but only 2 had more than four/h and there were
no complex forms of ventricular arrhythmia. The prevalence
of ventricular arrhythmias appears to increase during the
third decade of life. In 23 to 27 year old medical students,
ambulatory monitoring revealed at least one ventricular pre-
mature complex in 50% of the subjects (6).
From their survey of the literature, Sherman et al. (7)
concluded that the increase of ventricular arrhythmias in
men from age 16 to 74 years was exponential. No such
calculations were made for women, but no obvious sex
differences are apparent from the reported monitoring results
in different studies. A 24 hour ambulatory ECG showed
that the prevalence was 34% in 10I healthy women aged
20 to 59 years (8), 39% in 101 asymptomatic and healthy
men and women whose average age was 48.4 years (9),
46% in 147 active men aged 15 to 65 years (10), 62% in
men whose average age was 55 years (II) and 69 to 100%
in persons aged :::::60 years (12-16).
The prevalence of complex forms, that is, frequent or
multiform ventricular premature complexes, pairs and sal-
vos also appears to be greater in older persons. Thus, in a
study (13) of 98 asymptomatic subjects aged 60 to 85 years,
36% had >30 ventricular premature complexes/h, 35% had
multiform ventricular premature complexes, 11% had cou-
plets and 4% had ventricular tachycardia. Similar preva-
lences were reported in 106 healthy subjects aged >75 years
in England (12), and in subjects >80 years in France (14).
Of 10centenarians who underwent 24 hour ambulatory ECG
monitoring (16),9 had ventricular premature complexes and
3 had nonsustained ventricular tachycardia.
Prognostic significance. Crow et al. (17) reviewed the
available evidence, including their own 12,000 cases, and
concluded that a simple ventricular premature complex is
not an independent risk factor for future heart disease or
sudden cardiac death. In 482 insured men (18), ventricular
extrasystoles were not associated with increased mortality
during an average follow-up of 18 years. Similar conclu-
sions were reached by others (10,11,19-21). In one study
(10) of a group of men in whom the prevalence of ventricular
premature complexes was 46%, no deaths occurred because
of heart disease during a 6 year follow-up. In another study
(20) of 27 individuals with frequent ventricular premature
complexes, all subjects remained well at a mean interval of
8 months. A long-term (average 6.5 years) follow-up of 73
asymptomatic subjects who had frequent and complex ven-
tricular arrhythmia including ventricular tachycardia (in 26%)
showed no increased risk of death compared with that of
the healthy U.S. population (21). Also, no instances of
sudden death occurred in 54 subjects with ventricular pre-
mature complexes (37% complex forms) followed up for an
average period of 8.3 years (22).
In infants and children, the prognosis of ventricular ar-
rhythmias is believed to be uniformly excellent (23). At the
other end of the life span, Camm et al. (12) followed up
106 healthy subjects >75 years for 18 months. Ventricular
arrhythmias were present during ambulatory ECG monitor-
ing in 69%, but there was no difference in the arrhythmia
spectrum in 13 subjects who died during the follow-up,
compared with the group as a whole. In the Baltimore Lon-
gitudinal Study on Aging (24), 10 (I. 1%) of the healthy
asymptomatic volunteers had exercise-induced ventricular
tachycardia. Only one of these was <65 years old. Other
findings in these subjects with ventricular tachycardia were
not different from those in other healthy persons, and no
one died suddenly or had syncope during a 2 year follow-
up period (24).
Isolated cases ofsustained ventricular tachycardia in the
absence of detectable heart disease are reported in almost
all of the large series of patients with this condition. In these
cases, a "primary electric disease" of the heart is usually
postulated, but few studies have included cardiac biopsy to
rule out incipient heart disease. Sustained ventricular tachy-
cardia can occur in children without evidence of heart dis-
ease, but the cases are rare and no deaths were reported
during a long-term follow-up period (25).
Cases of sudden cardiac death due to ventricular fibril-
lation in the absence of demonstrable heart disease have
been reported, but their rarity relegates them to the category
of single case reports (26). In children, sudden death related
to ventricular arrhythmias nearly always occurs in patients
with an abnormal heart (27).
In conclusion. it appears that the presence of simple or
complex ventricular arrhythmias, including short runs of
ventricular tachycardia (sustained ventricular tachycardias
appear to be extremely rare in the absence of heart disease),
does not increase the risk of either cardiac death or sudden
death. Evidence to the contrary has been reported in some
longitudinal epidemiologic studies (28,29). However, the
significance of increased mortality in subjects with ventric-
ular premature complexes in these reports is open to question
because of the low yield of arrhythmia detection in single
ECGs made at rest, the limited amount of information about
cardiac function, the small number of deaths and the ad-
vanced age of many victims.
Ventricular Arrhythmias in Patients With
Heart Disease and Well Preserved
Ventricular Function
In this category, exercise and ambulatory ECG moni-
toring studies have been carried out most frequently in pa-
tients with coronary artery disease without a history of myo-
cardial infarction. Studies of patients with other heart diseases
are fewer in number. It appears that the incidence and com-
plexity of ventricular arrhythmias increase in the presence
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of heart disease even when cardiac function is not appre-
ciably impaired.
Ambulatory monitoring of patients with coronary ar-
tery disease. Of 92 patients with normal left ventricular
ejection fraction studied after coronary artery bypass op-
erations (30) , 57% had complex ventricular arrhythmia and
21.5% had nonsustained ventricular tachycardia. The in-
cidence of complications in patients with complex ventric-
ular arrhythmias was not higher than in other patients. and
there were no cardiac or sudden deaths during the follow-
up period, which averaged 16 months. The investigators
concluded that complex ventricular arrhythmias do not in-
dicate poor prognosis in individuals with good left ventric-
ular function. In 130 patients with chronic stable angina
pectoris randomized to medical or surgical therapy (31),
complex ventricular premature complexes during 6 hour
ECG monitoring were present in 30% of surgical and 15%
of medical patients but there was no difference in mortality
between the two groups, and the complex arrhythmias were
not associated with an increased risk of sudden cardiac death.
Thrombolysis using streptokinase intravenously was fol-
lowed by ventricular arrhythmias in all patients during the
first 24 hours after reperfusion (32) . Although couplets oc-
curred in 96% and nonsustained ventricular tachycardia in
89% of patients during the early period, none of these pa-
tients had serious ventricular arrhythmias at the time of
discharge.
Valvular heart disease. In the study of Uretzet al. (33),
frequent and complexventricular premature complexes were
present in 66% of 56 patients with valvular disease but in
only 33% of 73 persons without heart disease. Review of
the published data suggests that sustained ventricular tachy-
cardia and sudden cardiac death are not common in patients
with valvular disease and good ventricular function. In one
series of patients with aortic valve replacement (34), only
six death s occurred in 236 patients (4% ) during a mean
follow-up period of 62 months.
In a study (35) of 45 patients followed up for an average
of 14 months after aortic valve replacement, severity of
ventricular arrhythmias appeared to correlate with the im-
pairment of left ventricular function, and the postoperative
improvement of left ventricular function was usually ac-
companied by reductionof frequent and complex ventricular
prematurecomplexes. In patients with mitral valve prolapse
(36), frequentand complex ventricular prematurecomplexes
were more strongly associated with hemodynamically im-
portant mitral regurgitation than with mitral valve prolapse
alone.
In conclusion , it appears that the presence of simple and
complex ventricular arrhythmias, including short runs of
ventricular tachycardia, does not increase the risk of sudden
cardiac death in patients with heart disease and well pre-
served ventricular function.
Ventricular Arrhythmias in Survivors of
Myocardial Infarction
This is a most intensively studied category of patients.
In many of the earlier studies (37- 42), ventricular arrhyth-
mias recorded at various time intervals after infarction were
considered to be independent predictors of increased mor-
tality and sudden cardiac death. The validity of these con-
clusions is difficult to document because of the nonuniform
methodology of arrhythmia detection and either absent or
incomplete studies of hemodynamics, coronary anatomy,
left ventricular function and wall motion abnormalities in
these early studies.
Many of the recent studies (43-50) have established a
strong link between the severity of ventricular arrhythmias ,
sudden cardiac death and impaired ventricular function . A
very high incidence (6 1%) of sudden cardiac deaths due to
arrhythmias and myocardial rupture was associated with
ventricular aneurysm (43) . Other serious risk factors for
sudden cardiac death included the extent of myocardial in-
farction (44.45). low ejection fraction or poor left ventric-
ular function (46- 49) and the presence of major conduction
disturbances. congestive heart failure or sustained ventric-
ular tachycardia (50) .
Sustained ventricular tachycardia is believed to be as-
sociated with more severe myocardial damage (45,5 1) and
with large infarcts (52). Of 40 patients with sustained ven-
tricular tachycardia within 3 to 65 days after the onset of
infarction (53), only 20 were alive after an average follow-
up time of 20 months, and 12 of 20 victims died suddenly.
In another study (52) of 53 patients in whom sustained
ventricular tachycardia or ventricular fibrillation occurred
within 3 to 60 days after the onset of myocardial infarction,
24.5% died during a follow-up period averaging 15 to 18
months.
Figure J shows the incidence of sudden cardiac death
in the survivors of myocardial infarction from published
studies in which the number of patients exceeded 60, the
duration of follow-up averaged at least 12 months and the
incidence of sudden cardiac death was either stated or could
be estimated from the reported ratio of sudden death to total
death. In eight studies (46,47,54- 59) the follow-up period
averaged 12 to 18 months and in two (46,47) of them all
sudden deaths occurred in patients with a low ejection frac-
tion. This may account for a relatively high incidence of
sudden cardiac death in these two studies. In another study
(54) in which the 10.2% incidence rate of sudden cardiac
death was two to three times higher than in most other
studies, a low ejection fraction was an important risk factor
but there was also a high incidence rate of ventricular tachy-
cardia (11.6%), and the statistical analysis showed that ar-
rhythmia was an independent risk factor for sudden cardiac
death. In other studies (55-59), the incidence rate of sudden
M
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Figure 1. Incidence of sudden car-
diac death at a reported average fol-
low-up time in 21 studies (25 patient
groups)from the followingreferences:
at 12months(58.67-70); at 14months
(72); at 15 months (59); at 18 months
(71); at 22 months (78); at 24 months
(73.80); at 25months (74);at 33 months
(75); at 36 months (50.52,76); at 38
months (81); at 42 months (49); at 48
months (54); at 60 months (82); and
at 84 months (53). The number of pa-
tients participating in each study is
shown next to each symbol. The two
circled dots designate two studies
(46,47) in which all victims of sudden
cardiac death had a low ejection frac-
tion. The four pairs of triangles con-
nected by vertical lines represent beta-
adrenergic blocker trials (60- 63) with
alprenolol (A) , propranolol (P). ti-
molol (T) and metoprolol (M) . In each
of these trials, the group treated with
beta-adrenergic blockers has a lower
incidence of sudden cardiac death than
does the placebo-treated group. Two
computed regression lines have been
drawn. The lower line shows the per-
cent of sudden cardiac death (y) as a
function of average follow-up time in
months (x) weighted by sample size
(y = 2.45 + 0.956x; r = 0.50; P <
0.001). The upper line shows the same
relation when each study has equiva-
lentweight(y = 3.5 1 + O.lll x;r =
0.58; P = 0.003). Note that the
weighted line intercepts the 12 month
follow-up period at 3.6%, and the un-
weighted line at 4 .8 %.
cardiac death ranged from 2.7 to 5.4%. A low ejection
fraction or impaired ventricular function was an important
risk factor for sudden card iac death (56-58). Kleiger et al.
(56) attributed increased risk of sudden cardiac death to
poor ventricular function , but not to runs of ventricular
tachycardia . In the Multicenter International Study (59), the
incidence of sudden death after an average follow-up period
of 14 months was 2.7%; some of the patients in the study
were treated with practolol and some were receiving pla-
cebo, but the difference between the mortality rates in these
two groups was not signific ant.
Studies in which the average follow-up ranged fr om 22
to 36 months include fo ur trials ofbeta-adrenergic blockers
(60-63). In each of these, the incidence of sudden card iac
death was lower in the patients recei ving a beta-blocker than
in those rece iving placebo; that is, 2.6% for alprenolol ver-
sus 9.5% (60), 3 .3% for propranolol versus 4 .6% (6 1), 5 .0%
for timolol versus 10.1 % (62) and 6.1 % for metoprolol
versus 14.9% (63). In the Beta-blocker Heart Attack Trial
(BHAT) study (64) patients with congestive heart failure
had more frequent and complex ventricular premature com-
plexe s and the incidence of sudden cardiac death in pat ient s
with congestive heart failure during hospitalization was 5.5 %
in those treated with propranolol and 10.4 % in the placebo
group. The corresponding incidence in patients without
congestive heart failure was 2.9 and 3.3%, respectively . In
two other large studies (65 ,66), the incidence rate of sudden
cardiac death was 6.2 and 6.6%, respectively. In one of
these (65), ischemia preceded the terminal event in 66 % of
patients with witnessed arrhythmic death .
In three studies (38,40,67) in which the follow-up period
averaged 36 to 38 months, the incidence rate of sudden
cardiac death was 4.3 (67) , 5 .5 (38) and 5 .9% (40) , re-
spectively; hemodynamic assessment of patients in these
studies was not performed . In four studies (37 ,4 1,42,68) in
which the follow-up period averaged 42 to 84 months, the
incidence rate of sudden cardiac death was 9.4 (37),8 (42) ,
9.4 (68) and 14.3% (41), respectively; no hemodynamic
lACC Vol. 10, No.2
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Table 1. Two Ye ar Mortal ity in Relation to Frequency of Ve ntricu lar Premature Complexes/h
and to Left Ventricular Eject ion Fraction at the T im e of Hosp ital Disch arge After M yocardial
Infarction in 766 Patients
VPCs/h ( O/C)
LVEF 0 < I I to 2.9 3 to 9.9 10 to 29.9 ~30 Total*
"539% 20 1l.6 16 25 20 29 19 .1
(n = 256)
< 40% 3.4 6 8 17 12.5 8 9 .8
(n = 510)
*Of all deaths, 60.7% were attributed 10 arrhythmia, that is, 11 .5% in the lower ejection fraction group
and 6% in the higher ejection fraction group. See text for discussion . LVEF = left ventricular ejection fraction;
VPC = ventricular prematu re complex. (The data are rearranged. with permission. from Table 3 in Bigger JT
Jr , et al. [69].)
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assessment was performed in these studies. In one of these
(68), the incidence of sudden cardiac death shown in Figure
I may not be entirely accurate because the follow-up was
incomplete.
Of particular interest are three recent studies included
in Figure J (57.58.69) because of careful evaluation of
ventricular function in large groups of patients. In two of
these (58,59), ventricular arrhythmia was an independent
risk factor for sudden cardiac death, In the Multicenterstudy
(69), 866 survivors of myocardial infarction were followed
up for 2 years; there were 89 deaths, of which 54 were
attributed to arrhythmias. The left ventricular ejection frac-
tion in this group is not listed separately, but the study
concludes that " ventricular arrhythmias and left ventricular
dysfunction are independently related to mortality risk."
From Table 3 in that paper (69), I rearranged the data to
separate the patients into two categories, that is, 256 with
an ejection fraction <39% and 510 with an ejection fraction
> 40% (Table I), This table shows the relation between 2
year mortality and the frequency of ventricular premature
complexes in these two groups, In each category, the mor-
tality is higher in subjects with a low ejection fraction , and
in neither group does the mortality increase progressively
with increasing ventricular premature complex frequency .
In the MiLlS study (58) , 533 survivors of myocardial
infarction were followed up for an average of 18 months,
and the conclusion was that " the presence of frequent [ven-
tricular premature depolarizations] in association with left
ventricular dysfunction identifies patients at high risk for
sudden death over the next 7 months," This conclusion is
based on their data, reproduced in Table 2, which show that
the incidence of sudden cardiac death in patients with a left
ventricular ejection fraction > 40%, that is, Groups A and
C. was 8 (2,3%) of 352, and in those with an ejection
fraction < 40%, that is, Groups B and D, 21 (11.6%) of
181. This is a highly significant difference (p < 0,00I).
Also the difference between the incidence of sudden death
in GroupA versusGroup B is highlysignificant (p < 0.001).
This confirms the independent significance ofleft ventricular
ejection fraction. The independent statistical significance of
ventricular premature depolarizations > lO/h emerges from
thecomparison of Groups A and C. However, this is a weak
significance (p = 0.045) that ceases to exist (p = 0.168)
if only one of three cases of sudden cardiac death in Group
Table 2. Inc idence of Sudden Cardiac Death Durin g a 2 Year Foll o w-up in 533 Pat ients
Classified Int o Fou r Groups o n the Bas is of Left Ve nt ricu lar Ej ec tion Fra cti on > 40 % and
< 40%, and Ventricular Premature Depolarizat ion s > 10 and < 10/h
Sudden Cardiac Deaths p Value
Group A LVEF ~40% , VPD < 10th
Group B LVEF < 40%, VPD < IO/h
Group C LVEF ~40%. VPD ~ I O/h
Group D LVEF < 40%. VPD ~ 10/h
LVEF ~ 40% (A + C) vs. LVEF < 40%
In patients with VPD ~ IO/h:
In patients with VPD < IO/h:
VPD > IO/h vs. VPD < 10/h
In patients with LVEF ~400 :
In patients with LVEF < 400:
5 of 3 14 (2%)
14 of 141 (10%)
3 of ss (g%)
7 of 40 (18%)
(B + D) = 8 of 352 vs. 2 1 of 181
C vs. D = 3 of 38 vs. 7 of 40
A vs. B = 5 of 3 14 vs. 14 of 141
A vs. C = 5 of 3 14 vs. 3 of 38
B vs. D = 14 of 141 vs. 7 of 40
< 0.00 1
0 .3 12
< 0.00 1
0 .045
0 .260
Fisher' s exact test was used to evaluate the differences between groups. Discussion in text. LVEF = left
ventricular ejection fraction; VPD = ventricular premature depolarizations. (Reproduced with permission from
Mukharji J, et aI. 1581. )
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C is removed. * Maisel et al. (57) followed up 191 survivors
of non-Q wave myocardial infarction and 586 survivors of
Q wave infarction. The presence of complex ventricular
premature complexes at the time of hospital discharge was
an important predictor of mortality in patients with a non-
Q wave infarction but not in those with a Q wave infarction.
In the non-Q wave infarction group, the mortality rate was
19.4%. It was 8.8%, that is, 10 of 113, in those with
noncomplex ventricular premature complexes and 34.6%,
that is, 27 of 78, in those with complex ventricular pre-
mature complexes. Because approximately 50% of deaths
were classified as sudden, the 10% incidence rate of sudden
cardiac deaths within I year in this group is much higher
than in most other studies. The authors suggest that this
may be due to an "unstable ischemic state" in these pa-
tients.
In two studies (70,7l) not included in Figure 1, no re-
lation was found between sudden cardiac death and complex
ventricular arrhythmias in survivors of myocardial infarc-
tion, followed up for up to 12 years in one (70) and for 2
years in the other (71). In the latter study, sudden death
occurred in 4 of 31 survivors, but none of these had frequent
or complex ventricular premature complexes on the predis-
charge ambulatory ECG, whereas none of the 5 patients
who had such arrhythmias before discharge died suddenly.
Ventricular Arrhythmias in Other Patients
With Coronary Artery Disease
It has been firmly established (72-74) that the prognosis
of patients with coronary artery disease depends on the
severity and extent of the disease, and that at each level of
severity, mortality is augmented by the presence of scars
and aneurysm. In the study of Blevins et al. (75), the mor-
tality rate averaged 10% in patients with an ejection fraction
>40%, and 60% in those with an ejection fraction <40%.
The role of ventricular arrhythmias as an independent
risk factor remains uncertain. In the study of Califf et al.
(76), 23% of 1,293 patients (of whom 620 had significant
coronary artery disease) had ventricular arrhythmias during
treadmill exercise after coronary arteriography. Of these,
18% had simple ventricular premature complexes, 3% had
couplets and 2% had ventricular tachycardia. Arrhythmia
was a marker of left ventricular dysfunction and did not
contribute independently to the prediction of survival or
* Conversely, if the number of sudden cardiac deaths in Group C is
increased from three to four, the probability (p) value becomes 0.01.
Similarly, if the number of deaths in Group A is decreased from five to
four, the p value is 0.03, whereas if it is increased to six, the p value is
0.06. Thus, a change of only one death in either group can change the p
value to either nonsignificant or to more significant. This instability is
indicative of the weakness of the association. By contrast, a change of the
number of deaths in either direction in the groups with contrasting left
ventricular ejection fractions does not change the significance of Fisher's
exact test.
sudden cardiac death once the catheterization data were
known. These conclusions were challenged (69) because:
I) it was a stress test and not ambulatory monitoring of the
ECG; 2) patients admitted for evaluation of arrhythmia were
excluded; and 3) only 53% of patients had a history of
myocardial infarction, and in many the infarction was re-
mote. However, similar results were obtained in a study by
LichtIen et al. (77), who followed up 204 patients for an
average of 18.2 months; sudden cardiac death occurred in
9.3%. Both the sudden cardiac deaths and ventricular ar-
rhythmias occurred in patients with more severe left ven-
tricular dysfunction, and the severity of arrhythmias was
not an independent prognostic factor. In another study (78),
patients with an ejection fraction <30% had more ventric-
ular arrhythmias than did those with an ejection fraction
> 30%, and the prognostic factor of importance appeared
to be the presence of myocardial ischemia.
Ventricular Arrhythmias in Patients With
Severely Impaired Ventricular Function
Studies in these patients can be separated into two cat-
egories depending on whether the main focus of investi-
gation was primarily the treatment of congestive heart failure
or the treatment of symptomatic ventricular arrhythmias.
Class III to IV patients with congestive heart failure
due to ischemic or idiopathic dilated cardiomyopathy.
Packer (79) summarized the results of seven studies com-
prising 891 patients in whom the total mortality rate aver-
aged 37.4%, and the rate of sudden cardiac death 14.3%/year.
The incidence of ventricular tachycardia in different studies
ranged from 39 to 60%. Similar findings were present in
an additional eight studies (80-87) not reviewed by Packer
comprising a total of 398 patients. In these, the total mor-
tality rate averaged 42.4%, and the average incidence rate
of sudden cardiac death was 21.4% during a follow-up pe-
riod averaging 18.5 months and ranging from II to 34
months. The incidence rate of nonsustained ventricular
tachycardia in these studies ranged from 49 to 100%, and
averaged 65%.
In 9 of 13 of these studies in which the relation was
considered, sudden cardiac death was unrelated to nonsus-
tained ventricular tachycardia. Although the role of anti-
arrhythmic drugs received by many patients treated for
congestive heart failure has not been assessed, it remained
uncertain whether the treatment of arrhythmias in this cat-
egory of patients affected their survival (87,88). Also, the
incidence of nonarrhythmic death in patients with arrhyth-
mias is very high. In one study (86), ventricular tachycardia
was present in 26 of 35 patients. Of these, 80% died within
2 years, and only one of these deaths was attributed to
arrhythmia.
Even in those few studies (82-84) in which ventricular
lACC Vol. 10, No.2
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arrhythmia had an independent prognostic significance, the
correlation was not strong. For instance, in the study of
Holmes et al. (83), of 31 patients with ischemic and dilated
idiopathic cardiomyopathy, 9 had simple and 22 had com-
plex ventricular premature complexes. During the follow-
up averaging 25 months, 1 death occurred in the former and
13 deaths (11 sudden) in the latter group. However, although
complex ventricular premature complexes were an inde-
pendent risk factor for sudden cardiac death, a pulmonary
capillary wedge pressure > 16 mm Hg was present in 2 of
8 patients with simple, but in 19 of 22 patients with complex
ventricular premature complexes. In another study (82), 19
deaths (12 sudden) occurred after an average follow-up pe-
riod of II months in 74 patients with idiopathic dilated
cardiomyopathy. All patients who died had an ejection frac-
tion <40%. The left ventricular diastolic pressure and car-
diac index averaged II mm Hg and 3. I liters/min per rrr',
respectively, in the survivors, and 22 mm Hg and 2.5 li-
ters/min per rrr', respectively, in the victims of sudden car-
diac death. Ventricular tachycardia was present in 9 of the
12 patients who died suddenly and in 27 of the 62 survivors.
In yet another study (84) of 69 patients with dilated car-
diomyopathy, mortality at I year was 35%. Of 48 patients
with frequent, complex ventricular premature complexes
and nonsustained ventricular tachycardia, 14 died, and of
25 patients with no or rare premature ventricular complexes,
4 died. Multivariate analysis revealed that ventricular ar-
rhythmia contributed independently to mortality but could
not distinguish between death due to heart failure and death
due to arrhythmia.
Patients with symptomatic ventricular tachyarrhyth-
mias. Of six representative studies (75,89-93) in this cat-
egory, five include patients with sustained ventricular tachy-
cardia or those resuscitated from cardiac arrest (89-93) and
one (75) includes patients with frequent and complex ven-
tricular arrhythmias. In five of the six studies, 81 to 100%
of patients had either coronary artery disease or cardio-
myopathy, and in one study (89) only 72% had these di-
agnoses. Two groups were treated with amiodarone (92,93)
and the remaining with diverse drugs, including amioda-
rone. The total number of patients in these studies was 549,
the average follow-up was 14.8 months (8.5 to 24 months)
and the incidence of sudden cardiac death ranged from 8.2%
(89) in I year to 45.4% in 2 years (75). Severity of heart
disease was considered to be the strongest independent pre-
dictor of mortality in the two largest studies encompassing
239 in one (91) and 123 patients in the other (89).
Prognosis of Patients Resuscitated From
Cardiac Arrest
The survivors of cardiac arrest appear to be at high risk
of recurrences. In several studies (94-97), sudden death
occurred in 26% of 61 patients during a follow-up period
averaging 23.6 months (94), in 26.4% of 227 patients during
a follow-up period averaging 35 months (95), in 16% of 62
patients during a follow-up period averaging 22 months (96)
and in 12% of 139 patients during the first year (97). It has
been reported (68.98) that the prognosis of patients resus-
citated from ventricular fibrillation at the onset of myo-
cardial infarction is not worse than that of other survivors
of myocardial infarction. If, however, myocardial infarction
does not evolve after an episode of acute ischemia associated
with ventricular fibrillation, the resuscitated patients are at
higher risk of recurrences, presumably because the factors
that precipitated the initial episode have not ceased to exist.
In two studies (99, 100), sudden death occurred in 34% of
116 (99) and in 34% of 80 (100) survivors of cardiac arrest,
not followed by myocardial infarction, during follow-up
periods averaging 14 to 16 months. In one of these (100),
the prognosis correlated with the severity of left ventricular
dysfunction and of coronary artery disease.
R on T Phenomenon
Is it futile to control ventricular arrhythmias when the
ultimate outcome is determined by the condition of the heart?
This question was posed by Calvert et al. (10 I) while dis-
cussing their own findings, which showed that the incidence
and complexity of ventricular arrhythmias in 124 patients
monitored before coronary arteriography paralleled the se-
verity of coronary artery disease, myocardial asynergy and
level of left ventricular end-diastolic pressure. The answer
to this rhetorical question was "no," because it was pos-
tulated that the mere presence of ventricular arrhythmias
can create risk of a fatal "accidental discharge" during the
vulnerable period. This period is believed to correspond to
the terminal portion of the T wave, and a premature complex
interrupting the T wave has been referred to as the R on T
phenomenon. There is little doubt that the R on T phenom-
enon frequently initiates ventricular fibrillation in the pre-
hospital and early hospital phase of acute myocardial
infarction. Also, it frequently initiates a ventricular
tachyarrhythrnia, in particular torsade de pointes, in the
setting of hypokalemia or long QT interval of various origins
(102). However. under all other circumstances, the R on T
phenomenon is no more dangerous than is any other ven-
tricular premature complex (102).
This conclusion emerged from a review of studies (102)
that monitored patients with ventricular tachycardias during
the acute and late hospital phases of myocardial infarction,
survivors of myocardial infarction, miscellaneous patient
groups with ventricular arrhythmias, exercise-induced ven-
tricular tachycardias and subjects without heart disease. In
a number of these studies, ventricular tachycardia tended to
occur after a late rather than after an early ventricular pre-
mature complex. Therefore, in practice, the evaluation of
coupling intervals and prematurity indexes of the ventricular
442 SURAWICZ
PROGNOSIS OF VENTRICULAR ARRHYTHMIAS
JACC Vol. 10. No.2
August 1987:435-47
ectopic complexes has not influenced the clinical approach
to ventricular arrhythmias.
Sudden Cardiac Death
Sudden cardiac death may be unexpected in both its vic-
tim and its timing when it afflicts individuals not known
either to have heart disease or to be at risk of sudden death.
Alternatively, the death may be unexpected in time only
when the person is known to be at risk. In both categories,
in the adult population in this country, the vast majority of
victims have coronary artery disease. Since the advent of
coronary arteriography, it has been known that mortality
increases with the extent and severity of coronary artery
disease, and the presence of scars and aneurysms. Table 3
shows the mortality in the Cleveland Clinic study (72). The
incidence of sudden cardiac death is given only for persons
with absent or mild coronary artery disease. The calculations
from this small number of patients studied for 5 years show
that the incidence of sudden cardiac death/year per 1,000
population is about 10 times greater in subjects with s50%
coronary narrowing than in those without angiographic evi-
dence of coronary artery disease.
It has been estimated that 300,000 sudden cardiac deaths
occur each year in the United States (103). The incidence
of sudden cardiac death in person and time can be estimated
from long-term epidemiologic studies. In the Tecumseh study
(28),5,129 individuals past age 16 were followed up for 6
years, and 45 sudden deaths occurred during a 6 year follow-
up period; this gives an incidence of 1.46 sudden deaths/year
per 1,000 population. In the Framingham study (103), 112
sudden cardiac deaths occurred during a 26 year follow-up
of 5, 127 persons who were free of manifest coronary heart
disease at the time of examination, that is, there was an
incidence of 0.84 sudden cardiac death/year per 1,000 pop-
ulation. Inthe Manitoba study (104) of 3,983 male members
of the Canadian Air Force with a mean age of 30.8 years
at entry who were followed up for 30 years, the calculated
incidence was 0.58 sudden cardiac death/year per 1,000
population. In the male factory workers in Canton, North
Carolina who entered the study at the age of 35 to 69 years'
(105), the incidence of sudden cardiac death was 2.0/year
per 1,000 population. The Tecumseh and the Framingham
studies (28,103) appear suitable for a general estimate be-
cause they contain approximately equal numbers of men and
women. An average incidence of sudden cardiac death/year
per 1,000 population in these studies is 1.15. Because the
number of men > 30 and women >40 years equals about
107 million in the United States, the estimated number of
sudden cardiac deaths unexpected both in person and in time
is about 123,000. The remaining 177,000 will occur in
subjects with known heart disease. From Figure 1, the in-
cidence of sudden cardiac death does not appear to exceed
4 to 5% during the first year. The estimated number of
sudden cardiac death victims at the end of the first year is
36,000 to 45,000. This suggests that the remaining 132,000
to 141,000 victims are predominantly individuals with more
remote myocardial infarction and also those with cardio-
myopathy and other miscellaneous types of heart disease.
Common to all studies of sudden cardiac death was the
finding of higher incidence among male subjects, particu-
larly in the younger age groups, and the increasing incidence
with age in both sexes. In the Framingham study (106), the
risk of sudden death was increased threefold in the general
population with compared with those without ventricular
premature complexes. However, virtually all patients with
ventricular premature complexes who died suddenly had
other ECG abnormalities. Also, in persons with known coro-
nary artery disease, the proportion of those who died sud-
denly was the same among those with and without ventric-
ular arrhythmias. This finding complements the evidence
obtained from the monitoring studies discussed earlier that
ventricular arrhythmias are not causally related to sudden
death.
Table 3, Results of a 5 Year Follow-up in the Cleveland Clinic Study of Patients Undergoing
Coronary Angiography and Not Treated Surgically
Coronary Arteries
Normal
<30% Narrowing
30 to 50% Narrowing
<50% One vessel
>50% Two vessels
>50% Three vessels
> 50% Left main
coronary artery
No. of Patients
342
101
57
202
233
118
37
Total Cardiac
Deaths
[No. (%)J
2 (0.6)
6 (5.9)
3 (5.3)
29 (14.4)
88 (37.8)
63 (53.4)
21 (56.8)
Sudden Cardiac
Deaths
[No. (%)J
2 (0.6)
2 (2.0)
3 (5.3)
SCD
Incidence per
I,OOO/year
1.17
3.96
105
See text for discussion. SCD = sudden cardiac death. (Reproduced with permission from Bruschke AVG
et al. [721.)
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Uniqueness of Electrical Accidents Causing
Sudden Death
The lack of relation between ventriculararrhythmias and
sudden cardiac death makes the ventricularpremature com-
plex hypothesis of sudden cardiac death (107) untenable.
and suggests that electrical disorganization is a result of a
unique accident related to the presence of a unique electro-
physiologic abnormality. or a unique constellation of such
abnormalities . Two such abnormalities have been suggested
in the discussion of the R on T phenomenon, association
with a long QT interval and presence of acute myocardial
ischemia. Of these, myocardial ischemia is, by far, nu-
merically more prevalent.
The strongest evidence implicating myocardial ischemia
as the cause of fatal electrical accidents is the timing of
ventricular fibrillation in patients with acute myocardial
infarction. In these, ventricularfibrillation occurs frequently
during the prehospital or early hospital phase ( 108- 110) but
seldom occurs thereafter. In one study (III ) of 98 patients
who constituted 20% of alI cases of acute myocardial in-
farction , ventricular fibrilIation occurred in alI but I within
10 hours after the onset of symptoms.
Ischemia is implicated when ventricular fibrillation is
preceded by ST segment depression during or after exercis e
or by ST segment elevation induced by coronary spasm
(112.113). Serious ventricular arrhythmias have been re-
cordedduring variantangina pectoris episodes in about 50%
of patients (114, lIS ). These arrhythmias have occurreddur-
ing maximal ST segment elevation (occlusion arrhythmias)
(114-116) or during resolution (reperfusion arrhythmias)
(117) . In a study (118) of 114 patients with variant angina
followed up for an average of 26 months, 6 died suddenly
and 13 were resuscitated from cardiac arrest; ST segment
elevation wasgreater in the sudden death-cardiac arrest group.
The link between arrhythmias and ischemia was also sug-
gested by observations that maximal ST segment elevation
was significantly greater in patients who had occlusion ar-
rhythmias than in those who had no arrhythmias (1 14, 115),
that complex ventriculararrhythmias tended to occur when
the ST segment elevation was increasing or reaching max-
imum ( 119) and that the severity of ventricular arrhythmias
was related to the magnitude of ST segment elevation and
other markers of ischemia (120).
To be valid, the ischemia hypothesis of sudden cardiac
death requires proof that effective treatment and prevention
of myocardial ischemia reduces the incidence of sudden
cardiac death. The evidencesuggestive of this is the reduced
incidence of suddencardiacdeath in survivors of myocardial
infarction treated with beta-adrenergic blockers and in cer-
tain patients after coronary artery bypass graft operations.
It is of interest that in the BHAT study (121), propranolol
was equally beneficial in patients with and without ventric-
ular arrhythmias. The benefit of preventive therapy may be
difficult to demonstrate in individual patients, but cases of
ventricular tachycardia or ventricular fibrillation ceasing to
recur after coronary artery bypass operation (122) or after
percutaneous angioplasty (123) have been reported.
Lethal arrhythmias associated with a long QT interval or
an abnormal repolarization may be related to increased dis-
persion of ventricular repolarization or triggered afterde-
polarizations, or both (102). Barring the unrecognized or
latentcases of congenital long QT syndrome, mostelectrical
accidents of this type can be reduced substantially by the
prevention of contributing factors such as hypokalemia, hy-
pomagnesemia (?), fad diets and adverse effects of certain
antiarrhythmic and certain psychotropic drugs.
Therapeutic Implications
Although ambulatory ECG monitoring has documented
that the prevalence and complexity of ventricular arrhyth-
mias increase with age and severity of heart disease, there
are no established averages or ranges of frequency and com-
plexity expected for various ages, types and stages of heart
disease. The absence of norms makes it impossible to de-
termine whether any given finding deviates from the values
expected for the given individual. This. in tum, makes it
difficult to define therapeutic objectives in the absence of
symptoms.
There are no studies showing that treatment of arrhyth-
mias with drugs, other than the beta-adrenergic blockers,
reduces the incidence of sudden and nonsudden cardiac death.
Accordingly, the absence of independent prognostic signif-
icanceof ventriculararrhythmias impliesthat their treatment
should be confined to patients with serious symptoms. Pro-
phylactic use of antiarrhythmic drugs in asymptomatic or
mildly symptomatic patients is justifiable only in patient
groups for which evidence exists that ventricular arrhyth-
mias are moderately strong predictors of sudden cardiac
death. At this time, this has apparently been documented
only for patients with obstructive cardiomyopathy and non-
sustained ventricular tachycardia (124) , and the survivors
of non-Q wave myocardial infarction (57). However, even
in the latter patient group, the arrhythmia may be a marker
of myocardial ischemia.
Clinical Trials in Survivors of
Myocardial Infarction
The survivors of myocardial infarction form a cohort of
unique epidemiologic importance f or two reasons: I) they
represent numerically the largest population group at risk
of sudden cardiac death, and 2) they can be easily stratified
with respect to the risk factors and to the results of more
or less uniformdiagnostic studiesof cardiac function. These
patients, conveniently located in the hospital, become the
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most appropriate candidates for clinical trials designed to
test the role of various interventions on morbidity and mor-
tality, including sudden cardiac death. Of seven trials of
antiarrhythmic agents conducted so far, and summarized by
Furberg and May (125), in one, both the drug and the
placebo produced the same results; in two, the drug im-
proved the outcome, and in four, the drug worsened it.
However, in none of these studies did the results achieve
significance, possibly because of the small numbers of en-
rolled patients (range 150 to 630) and the exclusion of pa-
tients with severe ventricular arrhythmias.
It may be postulated that to achieve conclusive results
in trials of this type: 1) ventricular arrhythmias must con-
stitute a strong, independent risk factor; 2) the incidence of
sudden cardiac death in a group of subjects with fairly uni-
form characteristics must be substantial; and 3) the drug
used in the trial must be effective, nontoxic, affordable and
convenient to use. The foregoing literature survey fails to
provide an unequivocal answer to the question of whether
ventricular arrhythmias represent an independent risk factor
for sudden cardiac death in the survivors of myocardial
infarction. This cannot be attributed to either a paucity of
studies or an inadequate design of the conducted trials. Most
likely, the lack of conclusive results reflects either an absent
or, at best, a weak correlation between ventricular arrhyth-
mias and sudden death within a large pool of survivors of
myocardial infarction. Therefore, it would appear logical to
limit trials to those groups of patients in whom ventricular
arrhythmias represent a strong independent risk factor for
arrhythmic cardiac death.
Another drawback of studying a large pool of survivors
of myocardial infarction is inherent in wide variations of
the incidence of sudden cardiac death in different population
groups, some explained by known factors such as age and
ventricular function, others remaining unexplained (66). As-
suming the widely quoted occurrence of 1 million cases of
infarction in a year in the United States, a 10% hospital
mortality rate and an average 8% mortality rate during the
first year after infarction, there are 900,000 immediate and
828,000 1 year survivors of myocardial infarction. As cal-
culated earlier, the estimated number of sudden cardiac death
victims at the end of the first year is 36,000 to 45,000.
Assuming that a drug causes a 25% reduction of the inci-
dence of sudden cardiac death, 9,000 to 11,250 lives would
be saved during the first year by treating 900,000 survivors
of myocardial infarction during this period.
No trial can neglect serious difficulties in assessing the
results ofany drug therapy resulting from spontaneous var-
iability ofuntreated arrhythmias. Thus, in the study of Pratt
et al. (126) during two periods of placebo treatment in
symptomatic but not life-threatening ventricular arrhyth-
mias, the number of ventricular premature complexes de-
creased by 50%, of pairs by 65% and of ventricular tachy-
cardia by 85% during the second period of placebo
administration.
Another difficulty in evaluating the results of drug ther-
apy is the inability to distinguish between better drug tol-
erance and greater drug efficacy. In the study of 155 patients
by Velebit et al. (127), in 53 (34.2%) at least one drug
worsened the arrhythmia and in 80 (11.1 %) of 722 trials
the drug worsened or provoked arrhythmia. Also, the re-
sponse to antiarrhythmic therapy appears to depend on ven-
tricular function, being more effective in patients with a
higher left ventricular ejection fraction (128) and more dif-
ficult to suppress when the ejection fraction is low (75).
We gratefully acknowledge the help of Naomi S. Fineberg, PhD for sta-
tistical evaluation of the data.
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